We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Eirx Therap. | ERX | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.015 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.015 | 0.015 |
| Top Posts |
|---|
Posted at 28/4/2016 20:31 by amazon_woman Ok not sure what was paid out but it's not the bank that paid it out its the directors if they made preference payments ie made sure their chums got paid then in theory the liquidator can get the money back but the onus of proof lies with them unless they are connected parties ie family business partners etc Don't know enough about it but generally these actions don't succeed I think it's a red herring to point fingers at the bank they didn't action the payments Anyway this may or may not interest anyone here but I think this co looks vv interesting and just could recoup your losses here no advice just found it myself and think it's got good prospects It's best to move on from losses See what you think no guarantees of course I'm not mike ! 0Investors in oil/gas minnows who have lost heavily might be able to recover their losses and more by backing what I consider to be an absolute steal in HNR (Highlands Natural Resources). This is not a minnow miner as the name suggests, but a company that is in the process of undertaking field trials to prove the Divert Technology for refracking wells. The world leader in this space is Schlumberger, who are really on the hunt for a technology that can tackle this problem. If any reader needs evidence of the appetite that Schlumberger and other majors have for this type of thing, just look at the recent deal Schlumberger signed with Energy Recovery after 6 months of trials - they paid $75m upfront, coupled with a $50m first year milestone payment as well as considerable ongoing royalties. ERI shares more than trebled in price on the same day on that announcement (ERI had a market cap of $130 mln prior to the deal, rising to $440 mln on announcement of the deal). Divert, the offering from HNR, is said to be far superior relative to other offeringsAnyway, Schlumberger have already taken an interest in HNR/Divert and have signed a license deal to evaluate the trials which begin in a matter of weeks. They have further agreed that they have the right to subscribe to up to 33pc of HNR shares based on a five year NPV value of royalty income. The fracking/refracking market is a trillion dollar business. But, that is where it begins. The current market cap of HNR is, wait for it, a ludicrous $4mln. Yes dear readers, this is not a typing error. A mere £4mln. Moreover, it is not an AIM listed dud but has a full listing on the main market. The CEO has not taken a salary and has invested some £650k of his own cash. This from the Company: |
Posted at 22/9/2015 18:31 by asmodeus The conference referred to is the following:You are warmly invited to attend an action-packed Proactive Investors' One2One forum on the 24th September which features four London-listed growth companies. Presenting on the evening of the 24th September in Mayfair will be eg Solutions (LON:EGS), Motif Bio (LON:MTFB), Amphion Innovations (LON:AMP) & e-Therapeutics (LON:ETX). |
Posted at 02/2/2015 21:47 by skez13 Kties"successfully bringing claims against directors who have defrauded the company" will that also include, raising funds from private investors for a project that never materialised? |
Posted at 29/1/2015 13:36 by espeland2 Agreed, OD. AIM is a wonderful tool for getting investors' money out of them. I guess all of us who invested in it deserve nothing more. Luckily I got out of here in time to get at least some of my capital back, but it's a sobering thing to see names I remember still waiting and hoping. |
Posted at 15/1/2015 17:14 by smcl Agreed. We have had Mike111D talk rubbish for years on this stock as if he was the universal expert with insider knowledge. The guy knows nothing more than any other investor on this or any other bulletin board.Note the 'D'at the end of his name. D - I feel should stand for Dipstick - I suggest he includes a prefix of 'T' to read Mike111TD - i.e Total Dipstick'. Most appropriate considering the outcome here!! What a total waste. sm |
Posted at 20/12/2014 11:53 by alby220 I did try a general email to J.P in the light of the fact that the website is gone. On previous occasions J.P has responded to emails very quickly, this time he has not, up to now. As per other peoples comments, I must sadly agree with them, that I suspect this company has no hope of being resurrected . I hope I am proved wrong for all the investors including myself. |
Posted at 15/6/2014 22:14 by pwhite73 I see you've had the common sense to remove that pointless post. This is a proposed IPO not a listing or a relisting. If new investors cannot be found then existing share holders will be required to stump up even more money if the company is to stand a chance of a listing. |
Posted at 21/5/2014 20:54 by ewads Well, good on JP for that statement. He seems sincere that some investors monies may yet be salvaged in due course. Judging by the response on this BB today, there are many pi's still awaiting/checking in regularly for that glimmer of hope. This is still AIM though!Has it been three years? Seems like ten! |
Posted at 23/3/2014 21:08 by share_shark 23 Mar'14 - 20:57 - 2982 of 2982 0 0MORE FROM TODAYS SUNDAY TIMES. " There is a palpable sense that British investors are re-discovering a taste for biotech stocks, which have not been in favour for years. Last week's float of Circassia, which is developing treatments to prevent allergic reaction to cats and pollen, is a sure sign these stocks are coming back into vogue" |
Posted at 07/11/2013 12:00 by officerdigby As per usual nothing happens because of lack of funding!I guess biotech investors have hard time to swallow 0.18p for what exactly, revenue? licensing? milestone payments of... circa £40,000 I see.. hmmm... |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
